Introducing the fact that healing is aided by deliberate use of the subconscious.
Self improvement follows!
Psycho-neuro-immunology has been proved by medical scientists and is a specific self-improvement technique.
The fighting cell in the immune system (the T4 cell) is increased in meditation using guided imagery and visualization.
The end result is using the subconscious mind deliberately.
Dallas-based eTrak launched a breakthrough product line of location-tracking devices today incorporating a patent-pending “Hybrid Tracking System” utilizing Wi-Fi access points, Cell-ID and GPS to ensure pinpoint accuracy (as close as 10 feet) of a person, pet or object. Utilizing the Verizon Network, eTrak devices reveal their location using any computer or smartphone.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56056-etrak-launches-hybrid-location-tracking-system-wi-fi-cell-id-gps
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
BlackBerry Bold Touch 9900/Magnum (Unlocked Quadband) GSM Cell Phone Only 10.5mm thick, with a stainless steel frame and an attractive glass weave battery cover, the new Bold is a hybrid device, boasting both a 640x480 pixel capacitive touch screen and a full Qwerty keyboard. Underneath the skin, it’s a modern smartphone with a 1.2 GHz ARM processor and 768MB of RAM. The Bold also has 8GB of flash storage (expandable with up to 32GB of microSD cards).
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. While several leading cancer centers have only begun introducing immunotherapy, Issels has been a leader in Integrative Immunotherapy for decades.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7224051-issels-integrative-immunotherapy-lung-cancer-advanced-treatment
For many sports fans, it’s “that” time of the year. College and professional football season equate to prime time tailgating season. Fans seem to be tailgating more than ever as Tailgater Magazine estimates that 50 million people tailgate annually in North America.
Each year, tailgaters seem to try to compete for the biggest and best tailgates. Besides radios, blenders, and hot plates, it’s not uncommon to find big screen TVs, gaming systems, stereos, and of course, cell phone chargers at a typical tailgate this fall. All of this electronic equipment requires portable power to keep it running. Briggs & Stratton’s PowerSmart Series™ P3000 inverter generator takes tailgating to a whole new level for sports fans that require a quiet, lightweight, and fuel efficient portable generator to power all of their big game tailgating essentials.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7303151-briggs-and-stratton-powersmart-series-p3000-inverter-generator/
Janssen-Cilag International NV (Janssen) announced today that the European Commission has approved IMBRUVICA™ (ibrutinib) capsules, a first-in-class, once-daily, oral Bruton’s tyrosine kinase (BTK) inhibitor. This new approach to treating blood cancers works by blocking BTK, a protein that helps certain cancer cells live and grow.1 IMBRUVICA is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL), or adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy, or in first line in the presence of 17p deletion or TP53 mutation in patients unsuitable for chemo-immunotherapy.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/72762540-janssen-ec-approval-imbruvica-mcl-cll/
Texas Instruments (TI) (NASDAQ: TXN) today announced the new SimpleLink™ ultra-low power wireless microcontroller (MCU) platform that helps customers go battery-less with energy harvesting or enjoy always-on, coin cell-powered operation for multiple years. With this industry-first technology, customers have the flexibility to develop products that support multiple wireless connectivity standards using a single-chip and identical RF design. The SimpleLink ultra-low power platform supports Bluetooth® low energy, ZigBee®, 6LoWPAN, Sub-1 GHz, ZigBee RF4CE™ and proprietary modes up to 5Mbps. This platform expands TI’s SimpleLink portfolio, the broadest, lowest power and easiest to use wireless connectivity offering in the industry for the Internet of Things (IoT). For more information, visit www.ti.com/simplelinkulp.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/70647527-texas-instruments-simplelink/
House of Napius is India's first line of radiation safe maternity wear using path breaking NESA technology (Non-Ionizing Electromagnetic Shielding Alternatives.
Most expectant mothers understand that carrying a child means taking extra safety measures to protect the growing life. Mothers-to-be are aware that they need to avoid certain chemicals, foods, and some beverages. Our line of radiation safe maternity wear provides an additional safeguard by shielding against radiation from cell phones, wireless routers, laptop and computers. House of Napius offers a wide range of revolutionary, radiation safe Maternity wear for the first time in India.
With a lack of choice and growing radiation concerns Founder Director, Nehal Mehta says: “Today we cannot live a gadget or appliance free lifestyle. At House of Napius, we have created a solution to block the radiation from these gadgets which are used on a daily basis such as cellphones, microwaves, laptops, scanners and ipads. We are launching our first product category of maternity wear and will be expanding into other categories such a kidswear, womenswear and menswear in the future.”
When it comes to dressing during pregnancy, comfort and style are key factors/aspects. The new range of maternity wear by House of Napius includes office wear, day wear, resort, night wear and cocktail dresses. Each garment is designed to not only protect the child, but provide unparalleled comfort and ease of use for the pregnant mother. House of Napius maternity wear is available in a multitude of colours’ and patterns and will keep your child protected all through those precious nine months.
To view the Multimedia release go to:
http://www.multivu.com/players/English/7595451-house-napius-maternity-wear-india/
Want a sneak peek of the latest cell phone technology or newest flat screen TV? Are you anticipating the release of the newest appliances that will soon be featured in your kitchen?
The International Consumer Electronics Show (CES) is back! CES is the world’s gathering place for all who thrive on the business of consumer technologies. Held in Las Vegas every year, it has served as the proving ground for innovators and breakthrough technologies for more than 40 years—the global stage where next-generation innovations are introduced to the marketplace.
It’s not only the world's largest annual tradeshow for consumer technology, but it is also America's largest annual tradeshow of any kind. The first CES took place in New York City in June of 1967 with 200 exhibitors and 17,500 attendees. Since then, CES has grown more than seven-fold. CES now showcases more than 3,600 exhibiting companies, including manufacturers, developers and suppliers of consumer technology hardware, content, technology delivery systems and more and more than 150K attendees from 150 countries.
Nationally recognized consumer trends and technology expert Todd Townsend will provide viewers with a rare preview of some the latest technology available for 2016.
The sixth annual Productive Innovation Index released by IDEA Pharma today, which ranks biopharmaceutical companies by their ability to successfully bring innovations to market, sees Johnson & Johnson top the industry for the fourth year running.
The Productive Innovation Index measures, scores and celebrates a company’s ability to deliver innovation to patients, by objectively evaluating performance data based on a rolling five year period (2010-2015), and operates on the premise: if you gave the same molecule to two different companies in early phase, which would make the best of it?
The success of the Janssen Pharmaceutical Companies of Johnson & Johnson and its consolidation of 1st place across the past four years’ rankings is driven largely by innovations in the field of oncology, immunology, neuroscience and cardiovascular/metabolism. Notable performers include Zytiga® (prostate cancer), Imbruvica® (chronic lymphocytic leukemia and mantle cell lymphoma (co-developed and co-marketed with Pharmacyclics, an AbbVie company)), Simponi®/Simponi Aria® (rheumatoid arthritis), Stelara® (psoriasis and psoriatic arthritis), Invega Sustenna® and Invega Trinza® (schizophrenia).
To view the multimedia release go to:
http://www.multivu.com/players/uk/7770851-johnson-and-johnson-tops-idea-pharma/
